211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
The Readout Loud
00:00
Biote on Wall Street - What Does This Week End Hold and What Could It Do?
Biotex stocks have been in the do s, with one bench mark index down more than forty % in the last 12 months. What does this week end hold and what could it do for biote's terrible, horrible, no good, very bad year? Joining us to discuss that is jerrid holt's health care strategist with oppenheimer. Jerried: "I feel like the rebound, or the resuscitation of biote is going to take a while"
Transcript
Play full episode
